Brigitte Charlotte Widemann, M.D.
Pediatric Oncology Branch
Pharmacology and Experimental
Therapeutics Section
Investigator
National Cancer Institute
10 Center Drive
Building 10, Room 13C103
Bethesda, MD 20982
Fax: 301-480-8871
bw42y@nih.gov
Dr. Widemann is a tenure-track investigator at the NCI Pediatric Oncology Branch (POB). After obtaining her M.D. from the medical school of the University of Cologne, Germany, in 1986, Dr. Widemann became board certified in pediatrics in 1992 and was a hematology/oncology fellow at NCI POB from 1992 to 1995. Subsequently she joined the Pharmacology and Experimental Therapeutics Section of POB. Dr. Widemann’s primary research interests are the development of targeted therapies for refractory childhood cancers and for neurofibromatosis type 1-related tumors.
Dr. Widemann's Clinical Trials:
NCI is currently conducting the following trials for pediatric cancers and neurofibromatosis. Click on the trials below for additional details, including a summary of eligibility criteria, treatment plan, and information on how to contact the study team directly.
Back to Top
